MedTrace Logo

Perineural Steroids for Peripheral Nerve Blocks

NCT02462148 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2018-09-24

Study results available
· View outcomes & findings →

Summary

This study will look at the efficacy of dexamethasone for prolongation of peripheral nerve blocks.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Dexamethasone

Used in nerve block mixture

DRUG

Bupivacaine

Used in nerve block mixture

DRUG

Epinephrine

Used in nerve block mixture

PROCEDURE

Saphenous Peripheral Nerve Block

Peripheral nerve block.

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Daryl S Henshaw, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02462148 on ClinicalTrials.gov